- A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular…
Category: 6. Health
-
Heart Health Benefits Fade After Stopping GLP-1 Drugs
Share on Pinterest Stopping GLP-1s can quickly reverse the cardiovascular benefits gained while taking them. Image Credit: the_burtons/Getty Images -
AI-mammography leads to no significant benefits in single-reader study – AuntMinnie
- AI-mammography leads to no significant benefits in single-reader study AuntMinnie
- AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial Nature
- How artificial…
Continue Reading
-
More sleep and physical activity may prevent Type 2 diabetes in teens
Research Highlights:
- If adolescents replaced 30 minutes of sedentary time each day with sleep or moderate-to-vigorous physical activity, it may reduce their insulin resistance and thus reduce their risk of developing Type 2…
Continue Reading
-
Shifting Standards: Early ADC Use Complicates HER2+ MBC Treatment Paths
In a presentation at the 43rd Annual Miami Breast Cancer Conference, Giuseppe Curigliano, MD, PhD, of the University of Milano and Istituto Europeo di Oncologia in Milan, Italy, highlighted the growing complexity of treatment sequencing for…
Continue Reading
-
Higher blood pressure during young adulthood linked to heart & kidney disease after age 40
Research Highlights:
- A study of nearly 300 thousand adults in South Korea found that individuals with higher blood pressure (≥120 mm Hg/80 mm Hg) for up to 10 years during young adulthood (ages 30 and 40 were more likely to…
Continue Reading
-
AI Tool Shows Promise in Diagnosing Advanced Heart Failure | Newsroom
Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, Cornell…
Continue Reading
-
Faecal Microbiota Transplantation Improves Depression – EMJ
A NEW clinical study suggested that faecal microbiota transplantation (FMT) enhanced treatment response in adults experiencing depressive episodes when used alongside standard medication.
Depression remains a leading contributor to global…
Continue Reading
-
Gut microbes found to drive chronic kidney disease
Scientists have discovered how an imbalance in gut bacteria can accelerate chronic kidney disease, with early findings pointing to a potential drug that could interrupt the damaging cycle and improve outcomes.
Researchers have…
Continue Reading
-
Mpox Awareness at Sea: Guidance for Ship Operators and Crew | NorthStandard
Recent increases in mpox cases in several regions, including parts of Brazil and Central Africa, and the emergence of the…
Continue Reading
-
FIB-4 Score Reliability Questioned in Liver Screening
The FIBROSIS-4 (FIB-4) index may not reliably identify liver fibrosis in people with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a primary care study in Belgium and the Netherlands.
MASLD, previously known as…
Continue Reading